This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

FORMX (2014-07-17)

Starting date:
July 17, 2014
Posting date:
August 12, 2014
Type of communication:
Drug Recall
Subcategory:
Natural health products
Hazard classification:
Type II and III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-40771

Recalled Products

FORMX

Reason

Recall of lot # 410 was initiated after detection of potentially pathogenic micro-organisms in humans during microbiological analysis carried out by the Inspectorate Laboratory in Longueuil.

Type II for immunocompromised adults and those with conditions that may lead to a decrease in the integrity of the gastrointestinal tract (eg lesions) and Type III for the general adult population

Depth of distribution

Retailers in Quebec

Affected products

FORMX

DIN, NPN, DIN-HIM
No market authorization
Dosage form

Capsule

Strength
  • Epimedium brevicornum (143 mg/capsule)
  • Cordyceps sinensis (132 mg/capsule)
  • Panax ginseng (110 mg/capsule)
  • Lycium barbarum (88 mg/capsule)
  • Cinnamoni cassia extract (77 mg/capsule)
Lot or serial number

Lot # 410

Companies
Recalling Firm
9177-3531 Québec Inc
963 Rue Frank-Carrel, office 202
Quebec
G1N 2E6
Quebec
CANADA
Marketing Authorization Holder
Not Applicable

Date modified: